Publication: Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs
Issued Date
2015-03-02
Resource Type
ISSN
17509378
Other identifier(s)
2-s2.0-84928741163
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Infectious Agents and Cancer. Vol.10, No.1 (2015)
Suggested Citation
Nuttavut Kantathavorn, Chulabhorn Mahidol, Narongrit Sritana, Thaniya Sricharunrat, Natacha Phoolcharoen, Chirayu Auewarakul, Narongchai Teerayathanakul, Chantanee Taepisitpong, Siriporn Saeloo, Gaidganok Sornsamdang, Wandee Udomchaiprasertkul, Waraphorn Krongthong, Arpaporn Arnamwong Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs. Infectious Agents and Cancer. Vol.10, No.1 (2015). doi:10.1186/s13027-015-0001-5 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/35490
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs
Other Contributor(s)
Abstract
© 2015 Kantathavorn et al.; licensee BioMed Central. Background: Cervical cancer is the major cause of morbidity and mortality in Thai women. Nevertheless, the preventive strategy such as HPV vaccination program has not been implemented at the national level. This study explored the HPV prevalence and genotypic distribution in a large cohort of Thai women. Methods: A hospital-based cervical cancer screening program at Chulabhorn Hospital, Bangkok and a populationbased screening program at a rural Pathum Thani Province were conducted using liquid-based cytology and HPV genotyping. Results: Of 5906 women aged 20-70 years, Pap smear was abnormal in 4.9% and the overall HPV prevalence was 15.1%, with 6.4% high-risk (HR), 3.5% probable high-risk (PR), and 8.4% low-risk (LR) HPV. The prevalence and genotypic distribution were not significantly different between the two cohorts. Among HR-HPV genotypes, HPV52 was the most frequent (1.6%), followed by HPV16 (1.4%), HPV51 (0.9%), HPV58 (0.8%), HPV18 (0.6%), and HPV39 (0.6%). Among LR-HPV genotypes, HPV72 and HPV62 were the most frequent while HPV6 and HPV11 were rare. HPV infection was found to be proportionately high in young women, aged 20-30 years (25%) and decreasing with age (11% in women aged >50). The more severe abnormal cytology results, the higher positivity of HR-HPV infection was observed. Conclusions: In conclusion, HPV52, HPV16, and HPV51 were identified as the most common HR-HPV genotypes in Thai women. This study contributes genotypic evidence that should be essential for the development of appropriate HPV vaccination program as part of Thailand's cervical cancer prevention strategies.